Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from our phosphatase platform to modulate signal transduction imbalances. Signum’s phosphatase technology provides many opportunities for the development of novel pharmaceutical therapeutics. Signum has established a robust IP portfolio in the area of Signal Transduction Modulators (STMs). Signal transduction networks that regulate cellular activities have built-in global control mechanisms to coordinate their many interacting components. Signum has identified agents that perturb the two most central of these global regulatory mechanisms: G-Protein-Mediated membrane receptor signaling and Protein phosphorylation. G-Protein modulators (GPMs) regulate virtually all G-protein-mediated signaling activities and Phospho-Protein modulators (PPMs) regulate protein kinase phosphorylation networks. GPMs and PPMs can be used as cosmetics and dietary supplements to correct stressful imbalances that can be detrimental to health and well-being.
View Top Employees from Signum Biosciences, IncWebsite | http://www.signumbiosciences.com |
Revenue | $5 million |
Funding | $150000 |
Employees | 21 (21 on RocketReach) |
Founded | 2003 |
Address | 133 Wall Street, Princeton, New Jersey 80304, US |
Phone | (732) 329-6344 |
Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Life Science, Therapeutics, Health Care |
Web Rank | 3 Million |
Keywords | Biotech Boulder, Signum Biosciences |
Competitors | Aptahem, Biophytis - LIVE HEALTHIER LONGER, Cerecor, Inc., KBP Biosciences, Memory Pharmaceuticals Corp. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies |
Looking for a particular Signum Biosciences, Inc employee's phone or email?
The Signum Biosciences, Inc annual revenue was $5 million in 2024.
Michael Losch is the CFO of Signum Biosciences, Inc.
21 people are employed at Signum Biosciences, Inc.
Signum Biosciences, Inc is based in Princeton, New Jersey.
The NAICS codes for Signum Biosciences, Inc are [54, 5417, 54171, 541711, 541].
The SIC codes for Signum Biosciences, Inc are [283, 28, 80].